In the News
March 7, 2017 / News Page
Congressionally-directed Medical Research Program. It took over a decade of hard work from kidney cancer advocates to obtain kidney cancer-specific research funding included in the federal budget. Nevertheless, in March of 2017 Congress approved and the president signed the Consolidation Appropriations Act.Read More
November 10, 2016 / News Page
UT Southwestern - Cutting-edge Discoveries, Transforming Patient Care The American Cancer Society estimates that in 2014, 63,920 people were diagnosed...Read More
September 10, 2016 / News Page
UT Southwestern investigators report in Nature a new class of drugs against renal cancer, HIF-2 inhibitors, which are more efficacious...Read More
Funded major projects to date include:
RADVAX investigator led immunotherapy trial for 25 advanced kidney cancer patients at UT Southwestern combining Nivolumab, Ipilimumab and SBRT.
Support of UT Southwestern’s Kidney Cancer Research Program. 1 of only 2 SPOREs (Specialized Programs of Research Excellence) for Kidney Cancer in the US.